M Medraś, L Terpiłowski, D Kiełkiewicz, J Winowski, G Ziotas
{"title":"[Results of tests with clomiphene and choriogonadotropin in men with oligozoospermia treated with longterm antiestrogens].","authors":"M Medraś, L Terpiłowski, D Kiełkiewicz, J Winowski, G Ziotas","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The evaluation was made of the response to testosterone and oestradiol in the test (50 mg twice daily for 10 days) and HCG test (6000 units of Biogonadyl through 2 days) performed on 21 normospermic (fertile) males and on patients with normogonadotropic, idiopathic oligozoospermia, positively (12 patients) or negatively (24 males) reacting to the longterm Clostilbegyt treatment (50 mg daily for 240 days). It was shown that patients with oligozoospermia who do not react with an increase of spermatozoa during the longterm antioestrogen treatment had higher response of oestradiol in the dynamic test (+ 118.9%) than the normospermic males (+ 60.8%) or the oligozoospermic who showed positive semenologic response to the treatment (+ 58.8%). The similar reaction of oestradiol was shown in the HCG stimulation. In the hiperoestrogenism phenomenon the authors noticed the cause of lack of positive semenologic effects of the longterm antioestrogen treatment.</p>","PeriodicalId":76332,"journal":{"name":"Polski tygodnik lekarski (Warsaw, Poland : 1960)","volume":"51 6-9","pages":"73-4"},"PeriodicalIF":0.0,"publicationDate":"1996-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"19728567","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"[A trial use of the variable magnetic field in the symptomatic treatment of multiple sclerosis].","authors":"A Sieroń, G Cieślar, J Matuszczyk, J Zmudziński","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":76332,"journal":{"name":"Polski tygodnik lekarski (Warsaw, Poland : 1960)","volume":"51 6-9","pages":"113-5"},"PeriodicalIF":0.0,"publicationDate":"1996-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"19729522","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"[Pharmacologic treatment of mild proliferation of prostatic cancer].","authors":"S Dutkiewicz","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>In the paper, pathophysiological and clinical foundations of modern conservative therapy of mild proliferation of prostatic cancer are discussed in a short outline. The problems of treatment with hormonal and non-hormonal preparations are presented against the background of the mechanism of action of pharmacological preparations. The drugs, their dosage, effectiveness and also side effects are discussed. The importance is stressed of the drugs blocking the alpha-1 adrenergic receptors in the treatment of mild proliferation of prostatic cancer with additional beneficial mechanisms of action for the organism.</p>","PeriodicalId":76332,"journal":{"name":"Polski tygodnik lekarski (Warsaw, Poland : 1960)","volume":"51 6-9","pages":"67-72"},"PeriodicalIF":0.0,"publicationDate":"1996-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"19728566","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"[Antithrombin III and alpha 2-antiplasmin in blood of patients operated on for benign prostatic hyperplasia].","authors":"Z Zietek, I Iwan-Zietek, M Kotschy, F Tyloch","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The pre- and postoperative activity was studied of antithrombin III (AT III) and alpha 2-antiplasmin (alpha 2-AP) in blood of 40 patients subjected to transurethral prostatic electroresection due to benign prostatic hyperplasia (BPH). For comparison of the obtained results a control group was formed from patients with other diseases of the genitourinary system with exception of neoplasms. The activity of AT III and alpha 2-AP before the operation was similar to that in the control group. Intraoperatively (day 0) and on the first day after the operation, a statistically significantly lower activity of AT III and alpha 2-AP was found in the patients with BPH in relation to the initial value as well as to the control group. On day 5 after the operation, normalization of AT III and alpha 2-AP activity was found. During operations of the prostate a release occurs of thromboplastins and plasminogen activators initiating the activation of blood clotting and fibrinolysis. The decrease of activity of AT III and alpha 2-AP could be caused by AT III and alpha 2-AP use-up in the process of inhibition of the created thrombin and plasmin.</p>","PeriodicalId":76332,"journal":{"name":"Polski tygodnik lekarski (Warsaw, Poland : 1960)","volume":"51 6-9","pages":"75-6"},"PeriodicalIF":0.0,"publicationDate":"1996-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"19728568","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"[Prognostic factors and results of treating 42 patients with nln-seminomatous germ cell tumor of the testis].","authors":"Z Czownicki, J Rogozińska, B Choina","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>In 1984-1988, 42 patients with non-seminomatous germ-cell tumour of the testis were treated surgically in combination with chemotherapy. Actually, 21 (50%) patients live without any symptoms, 5 (12%) patients with the symptoms during treatment whereas 6 (38%) patients died. Survival period of cured patients was 10-50 months (median 29 months) while still treated patients--5-34 months (median 10 months). A relationship between clinical outcome and advancement and tumor weight was noted. A decrease in the velocity of tumor weight increase with time lapse was seen. Inherited defects of the uro-genital tract were diagnosed in 6 (14%) patients.</p>","PeriodicalId":76332,"journal":{"name":"Polski tygodnik lekarski (Warsaw, Poland : 1960)","volume":"51 6-9","pages":"82-5"},"PeriodicalIF":0.0,"publicationDate":"1996-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"19730234","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
I Iwan-Zietek, Z Zietek, M Kotschy, F Tyloch, E Zastawna
{"title":"[Activity of protein C in blood of patients with prostatic carcinoma].","authors":"I Iwan-Zietek, Z Zietek, M Kotschy, F Tyloch, E Zastawna","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The activity of Protein C in the blood of the patients with prostatic carcinoma and benign prostatic hyperplasia was examined. It was observed a slightly decrease of activity of protein C in the blood the patients with prostatic carcinoma. The observation of the activity of Protein C is useful because it allow to differentiate from patients with prostatic carcinoma a group of high risk of haemorrhagic complications. The activity of Protein C may be a prognostic factor of a progress of a prostatic carcinoma.</p>","PeriodicalId":76332,"journal":{"name":"Polski tygodnik lekarski (Warsaw, Poland : 1960)","volume":"51 6-9","pages":"94-5"},"PeriodicalIF":0.0,"publicationDate":"1996-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"19730238","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"[YAG:Nd laser cw in treatment of precancerous states of the penis].","authors":"B Kuzaka, K Szymańska, W Suleiman","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>In the paper the results are presented of treatment with laser light generated by a YAG:Nd cw laser of a patient with Queyrat disease and another patient with leukoplakia of the glans penis. As the result of the treatment carried out, the lesions revealed during six-month observation regressed completely, leaving no scars. No impairment of sexual functions was found in the treated patients.</p>","PeriodicalId":76332,"journal":{"name":"Polski tygodnik lekarski (Warsaw, Poland : 1960)","volume":"51 6-9","pages":"98-9"},"PeriodicalIF":0.0,"publicationDate":"1996-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"19730240","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"[Dr. Wilhelm Malcz as medical counsel for the Polish Kingdom (1831-1852)].","authors":"W Okniński","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":76332,"journal":{"name":"Polski tygodnik lekarski (Warsaw, Poland : 1960)","volume":"51 6-9","pages":"121-3"},"PeriodicalIF":0.0,"publicationDate":"1996-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"19729524","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"[Activity of alpha 1-antitrypsin in blood of patients with prostatic tumor].","authors":"Z Zietek, I Iwan-Zietek, M Kotschy, F Tyloch","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The activity of alpha 1-antitrypsin in patients with prostatic carcinoma and benign prostatic hyperplasia was examined. The activity of alpha 1-antitrypsin was higher in patients with prostatic carcinoma. The higher activity of alpha 1-antitrypsin is good prognostic sign for patients with prostatic carcinoma because it is born of large defense possibilities in these patients against the disease.</p>","PeriodicalId":76332,"journal":{"name":"Polski tygodnik lekarski (Warsaw, Poland : 1960)","volume":"51 6-9","pages":"89-90"},"PeriodicalIF":0.0,"publicationDate":"1996-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"19730236","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}